Clindamycin hydrochloride (oral): Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 15: Line 15:
==FDA Package Insert==
==FDA Package Insert==


'''  [[Clindamycin hydrochloridedescription|Description]]'''
'''  [[Clindamycin hydrochloride description|Description]]'''
'''| [[Clindamycin hydrochlorideclinical pharmacology|Clinical Pharmacology]]'''
'''| [[Clindamycin hydrochloride clinical pharmacology|Clinical Pharmacology]]'''
'''| [[Clindamycin hydrochloridemicrobiology|Microbiology]]'''
'''| [[Clindamycin hydrochloride microbiology|Microbiology]]'''
'''| [[Clindamycin hydrochlorideindications and usage|Indications and Usage]]'''
'''| [[Clindamycin hydrochloride indications and usage|Indications and Usage]]'''
'''| [[Clindamycin hydrochloridecontraindications|Contraindications]]'''
'''| [[Clindamycin hydrochloride contraindications|Contraindications]]'''
'''| [[Clindamycin hydrochloridewarnings|Warnings]]'''
'''| [[Clindamycin hydrochloride warnings|Warnings]]'''
'''| [[Clindamycin hydrochlorideprecautions|Precautions]]'''
'''| [[Clindamycin hydrochloride precautions|Precautions]]'''
'''| [[Clindamycin hydrochlorideadverse reactions|Adverse Reactions]]'''
'''| [[Clindamycin hydrochloride adverse reactions|Adverse Reactions]]'''
'''| [[Clindamycin hydrochlorideoverdosage|Overdosage]]'''
'''| [[Clindamycin hydrochloride overdosage|Overdosage]]'''
'''| [[Clindamycin hydrochlorideclinical studies|Clinical Studies]]'''
'''| [[Clindamycin hydrochloride clinical studies|Clinical Studies]]'''
'''| [[Clindamycin hydrochloridedosage and administration|Dosage and Administration]]'''
'''| [[Clindamycin hydrochloride dosage and administration|Dosage and Administration]]'''
'''| [[Clindamycin hydrochloridecompatibility reconstitution and stability|Compatibility, Reconstitution, and Stability]]'''
'''| [[Clindamycin hydrochloride compatibility reconstitution and stability|Compatibility, Reconstitution, and Stability]]'''
'''| [[Clindamycin hydrochloridedirections for use|Directions For Use]]'''
'''| [[Clindamycin hydrochloride directions for use|Directions For Use]]'''
'''| [[Clindamycin hydrochloridehow supplied|How Supplied]]'''
'''| [[Clindamycin hydrochloride how supplied|How Supplied]]'''
'''| [[Clindamycin hydrochloridelabels and packages|Labels and Packages]]'''
'''| [[Clindamycin hydrochloride labels and packages|Labels and Packages]]'''





Revision as of 17:11, 9 January 2014

Clindamycin hydrochloride
CLEOCIN HYDROCHLORIDE® FDA Package Insert
Description
Clinical Pharmacology
Microbiology
Indications and Usage
Contraindications
Warnings
Precautions
Adverse Reactions
Overdosage
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdurahman Khalil, M.D. [2]

For patient information, click here.

Overview

Clindamycin (rINN) (IPA: [klɪndəˈmaɪsən]) is a lincosamide antibiotic used in the treatment of infections caused by susceptible microorganisms. Clindamycin is a semisynthetic antibiotic derived from lincomycin by 7(S)-chloro-substitution of the 7(R)-hydroxyl group of the lincomycin. Clindamycin is marketed under various trade names including Dalacin (Pfizer), Cleocin (Pfizer), and in a foam as Evoclin (Connetics) and Duac(Stiefel).

Category

Lincosamides

US Brand Names

CLEOCIN HYDROCHLORIDE®

FDA Package Insert

Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings | Precautions | Adverse Reactions | Overdosage | Clinical Studies | Dosage and Administration | Compatibility, Reconstitution, and Stability | Directions For Use | How Supplied | Labels and Packages


References

http://www.accessdata.fda.gov/drugsatfda_docs/label/2004/50162s082,50441s045,50639s013lbl.pdf